Content Type: Research Publications

Regulatory Review Duration and Differences in Submission Times of Drugs in the United States and Europe, 2011 to 2020

March 6, 2026

Infections Following Bispecific Antibodies in Myeloma: a Systematic Review and Meta-Analysis

March 6, 2026

Market Dynamics of Authorized Generics in Medicaid From 2014 to 2020

March 6, 2026

Comparative Effectiveness and Safety of Generic Versus Brand-Name Fluticasone-Salmeterol to Treat Chronic Obstructive Pulmonary Disease

March 6, 2026

Changes in the Number of Continuation Patents on Drugs Approved By the FDA

March 6, 2026

Patents and Regulatory Exclusivities on GLP-1 Receptor Agonists

March 6, 2026

Securing the Trustworthiness of the FDA to Build Public Trust in Vaccines

March 6, 2026

Physician Perspectives on the Food and Drug Administration’s Decision to Grant Accelerated Approval to Aducanumab for Alzheimer’s Disease

March 6, 2026

Variation in Endpoints in FDA Medication Approvals: A Review of Acute and Preventive Migraine Medications

March 6, 2026

Why Pharmaceutical Patent Thickets Are Unique

March 6, 2026

The Impact of Electronic Health Record Discontinuity on Prediction Modeling

March 6, 2026

Physician Experiences with and Perceptions of Risk Evaluation and Mitigation Strategy Programs with Elements to Assure Safe Use

March 6, 2026